Skip to main content

Table 1 Changes in mortality of malignant tumors of the female reproductive system in China (1/105)

From: Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020

Year

Cervical cancer

Uterine cancer

Ovarian cancer

Total

CMR

ASMR

CMR

ASMR

CMR

ASMR

CMR

ASMR

2006

2.37

2.72

3.21

3.68

1.42

1.64

7.00

8.04

2007

2.94

3.29

3.56

4.02

1.65

1.86

8.14

9.17

2008

2.66

2.86

3.83

4.16

1.72

1.87

8.21

8.88

2009

2.90

3.02

3.73

3.86

1.86

1.95

8.49

8.84

2010

2.89

2.95

3.84

3.95

1.91

1.94

8.64

8.83

2011

2.85

2.75

3.58

3.47

1.78

1.69

8.21

7.91

2012

2.95

2.78

3.56

3.34

1.92

1.80

8.43

7.92

2013

3.27

2.95

3.61

3.23

1.87

1.67

8.76

7.85

2014

4.91

4.37

2.28

2.01

1.98

1.76

9.17

8.13

2015

5.30

4.72

2.01

1.78

2.08

1.85

9.40

8.35

2016

5.65

4.91

1.83

1.56

2.41

2.08

9.89

8.55

2017

5.68

4.91

1.88

1.61

2.53

2.16

10.09

8.69

2018

5.58

4.75

2.14

1.78

2.58

2.17

10.30

8.69

2019

5.39

4.33

2.52

1.97

2.86

2.25

10.77

8.55

2020

5.14

3.96

2.33

1.74

2.87

2.17

10.35

7.87

AAPC

4.86

2.16

 − 2.21

 − 5.21

5.03

1.87

2.54

 − 0.37

95% CI

1.33,8.51

 − 1.67,6.13

 − 6.23,1.98

 − 9.31, − 0.91

0.99,9.22

 − 1.7,5.57

2.07,3.00

 − 3.07,2.4

t

2.72

1.10

 − 1.05

 − 2.36

2.45

1.02

11.92

 − 0.27

P

0.007

0.273

0.296

0.018

0.014

0.309

 < 0.001

0.789

  1. AAPC Average annual percentage change; ASMR Age-standardized mortality rate; CMR Crude mortality rate